QUICK TAKE
The signal, without the leap.
The World Anti-Doping Agency's 2026 Prohibited List took effect on January 1, 2026. The current list and its summary of major modifications should be the decision source for athletes and support personnel—not a product page, forum post, or older list.
WHAT CHANGED
Key points from the source.
- 01
WADA updates the Prohibited List annually and publishes the controlling list with supporting modification and monitoring documents.
- 02
A substance's sport status answers a different question from whether it has human evidence or an FDA-approved medical use.
- 03
Class coverage and named examples both matter, so checking only whether a product label uses a familiar peptide name can be insufficient.
- 04
Athletes remain responsible for verifying the current rule, the exact substance, and any applicable therapeutic-use exemption process through official anti-doping channels.
WHY IT MATTERS
The decision boundary.
Peptide discussions frequently collapse medical, research, and competition rules into a single 'legal' label. That shortcut can produce a wrong answer for an athlete.
PeptideAgent therefore records WADA status independently from FDA status and evidence depth, with the official list as the governing source.
PRIMARY SOURCES